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Akathisia is a common side-effect of the 
neuroleptic drugs and occurs in about 5% to 
75% cases treated with these compounds (Bar-
nes et al., 1985; Van Putten et at., 1984). In 
addition, akathisia like syndromes are 
produced with conditions such as uremia, 
idiopathic restless legs syndrome, congestive 
heart failure, idiopathic parkinsonism, and with 
drugs such as reserpine, .trycyclic antidepres-
sants (Gibb et al., 1986; Zubenko et al., 1987) 
and diltiazem. 
In 1978, Zitrin et alreported that 18% of 
their cases in a series of patients with phobias, 
treated with imipramine developed a syndrome 
characterised by "insomnia, jitteriness ir-
ritability and unusual energy" on dosage ranging 
from 5-75mg/day. This is quite similar to 
akathisia, a side-effect also reported with the 
antidepressant fluoxetine by Lipinski et al. 
(1989). 
A single case report of akathisia as a. 
side-effect with fluoxetine is being discussed 
below. 
CASE HISTORY 
A 22 year old unmarried, north Indian 
male, visited our hospital clinic, with 3 year 
illness history, diagnosed as obsessive com-
pulsive disorder (OCD) with secondary 
depression. He was put on Fluoxetine, start-
ing with 20mg/day along with bed time 
diazepam 5mg. He had been drug free for 
almost 15 days, and prior to this he had been 
treated with a variety of antidepressants, 
alone and in combination with other 
psychopharmacological agents. He seemed to 
have been unresponsive to imipramine, 
amitriptyline, nitroxazepine given along with 
lithium, low doses of haloperidol and 
thioridazine, in different combinations. How-
ever not all drugs were precribed in adequate 
doses and for sufficient length of time to actual-
ly call him resistant to treatment with these 
compounds. He was prescribed fluoxetine in 
view of its established efficacy in OCD and also 
in depressive illness. 
Two weeks later when he came for his 
scheduled follow up, he was not taking 
fluoxetine, as he reported to have 
developed marked restlessnes, anxiety, in-
somnia, inability to sit still on the 5th day of 
medication with 20mg/day morning dose of 
fluoxetine. He was prescribed phenargan 25 
mg thrice a day by a local psychiatrist in his 
city, whom he contacted with these com-
plaints, and he felt relieved of these 
symptoms within two days. 
On this follow up visit he had no such 
complaints and he had been off medicines for 
almost 8 days. He was reassured and advised to 
restart fluoxetine 20mg/day, considering his 
complaints to be temporary side-effects with 
the drug, which would pass off after a few days. 
On the 6th day, he was back in the hospital, very 
anxious, restless, jittery, and unable to keep his 
legs still, and unable to sit still, with an urge to 
move about with which he felt better. The sub-
jective experience and his appearance sug-
gested the possibility of akathisia which is not 
mentioned as a side-effect in the product 
monograph of fluoxetine, but anxiety, nervous-
ness and insomnia is reported in about 10%-
15% of treated patients (Stark et al., 1985). 
There was no sign of parkinsonism or dystonia 
or any other finding on examination. 
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He was then advised diazepam 
lOmg/day along with propranolol 40mg/day ad-
ditionally, both in three divided doses, with 
which he felt better around 2nd & 3rd day, with 
symptoms reappearing on discontinuation of 
these. He was later shifted to imipramine 
therapy and fluoxetine was totally discontinued 
because the patient refused to continue to take 
it. 
DISCUSSION 
Review of the literature on fluoxetine 
brought to light a paper by Lipinski et al. (1989), 
reporting 5 cases of akathisia induced by 
fluoxetine. Three out of these five cases 
developed akathisia on the 5th day on 60 mg/day 
of fluoxetine, one within 12 hours on 20mg/day 
and the 5th after hours on a dose of 40mg/day. 
Fluoxetine induced akathisia is indistin-
guishable from neuroleptic akathisia, but is 
milder, and usually comes around the 5th day. 
Tolerance may develop to it, but it is relieved by 
either decreasing the dose of fluoxetine or ad-
ministration of propranolol, an adnergic recep-
tor antogonist. Akathisia in these cases is not 
associated with signs and symptoms of parkin-
sonism or dystonia, which almost always accom-
pany neuroleptic induced akathisia. Figures of 
its exact incidence have to be worked out but is 
estimiated to be between 9.8% - 25% (Lipinski 
era/., 1989). 
The tricyclic induced jitteriness 
syndrome is identical to the syndrome 
produced by fluoxetine and both are clinically 
identical to akathisia (Zubencoefal., 1987)., The 
case history reported suggests akathisia as a 
side-effect of fluoxetine, since the patient was 
drug free for over 2 weeks before institution of 
fluoxetine which was not combined with any 
other drug likely to produce akathisia. 
Lipinski et al., have suggested the prob-
able patho-physiology of fluoxetine induced 
akathisia. Akathisia follows the inhibition of 
dopaminergic neilrone in the Ventral tegmental 
area (VTA). Fluoxetine and other compounds 
that enhance serotonergic transmission (in-
cluding Tricyclic anti-depressants (TCA'S) and 
Mono-amine Oxidase Inhibitor's (MAOI'S)) 
produce akathisia, by enhancing serotonergi-
cally mediated inhibition of Dopamine (DA) 
cells in the VTA, producing DA defiency and 
thus akathisia (Lipinski et al., 1989). 
The case report is relevant because of 
the recent introduction of fluoxetine in the In-
dian market. Combination of fluoxetine with a 
neuroleptic compound may increase the risk of 
developing akathisia with fluoxetine. Moreover 
controlled prospective studies to determine its 
true incidence can be carried out. 
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